Endothelin-1 antagonist selectively modulates tumor blood flow and potentiaites responses to both chemotherapy and radiotherapy

(2004) 16th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics — Location: Geneva, Switzerland (28.September.2004)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 277.3 KB

Details

Authors
Affiliations

Citations

Martinive, P., Sonveaux, P., Dessy, C., & Feron, O. (2004). Endothelin-1 antagonist selectively modulates tumor blood flow and potentiaites responses to both chemotherapy and radiotherapy. EJC - Supplements, 2(8), 181-182. https://doi.org/10.1016/S1359-6349(04)80608-6 (Original work published 2004)